Targeting the Nogo Receptor to Treat Central Nervous System Injuries
- 1 November 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (11) , 872-879
- https://doi.org/10.1038/nrd1228
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Annual Incidence of First Silent Stroke in the United States: A Preliminary EstimateCerebrovascular Diseases, 2003
- Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesionsAnnals of Neurology, 2001
- Inhibitor of neurite outgrowth in humansNature, 2000
- Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1Nature, 2000
- Identification of the Nogo inhibitor of axon regeneration as a Reticulon proteinNature, 2000
- Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growthNeuron, 1994
- A novel role for myelin-associated glycoprotein as an inhibitor of axonal regenerationNeuron, 1994
- Structure and chromosomal localization of the gene for the oligodendrocyte-myelin glycoprotein.The Journal of cell biology, 1990
- Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading.The Journal of cell biology, 1988
- A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes.The Journal of cell biology, 1988